Cargando…
New Evidence on Carbetocin: Another Arrow in Our Quiver
Carbetocin is more heat stable than oxytocin with at least equivalent efficacy for preventing postpartum hemorrhage. It will certainly be helpful if the supplier can make it available in low-income country settings at a price comparable to oxytocin. But even so, programs will still need oxytocin and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health: Science and Practice
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172116/ https://www.ncbi.nlm.nih.gov/pubmed/30287526 http://dx.doi.org/10.9745/GHSP-D-18-00336 |
_version_ | 1783360879149973504 |
---|---|
author | Hodgins, Steve |
author_facet | Hodgins, Steve |
author_sort | Hodgins, Steve |
collection | PubMed |
description | Carbetocin is more heat stable than oxytocin with at least equivalent efficacy for preventing postpartum hemorrhage. It will certainly be helpful if the supplier can make it available in low-income country settings at a price comparable to oxytocin. But even so, programs will still need oxytocin and other uterotonic medications. |
format | Online Article Text |
id | pubmed-6172116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Global Health: Science and Practice |
record_format | MEDLINE/PubMed |
spelling | pubmed-61721162018-10-21 New Evidence on Carbetocin: Another Arrow in Our Quiver Hodgins, Steve Glob Health Sci Pract Editorials Carbetocin is more heat stable than oxytocin with at least equivalent efficacy for preventing postpartum hemorrhage. It will certainly be helpful if the supplier can make it available in low-income country settings at a price comparable to oxytocin. But even so, programs will still need oxytocin and other uterotonic medications. Global Health: Science and Practice 2018-10-03 /pmc/articles/PMC6172116/ /pubmed/30287526 http://dx.doi.org/10.9745/GHSP-D-18-00336 Text en © Hodgins. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-18-00336 |
spellingShingle | Editorials Hodgins, Steve New Evidence on Carbetocin: Another Arrow in Our Quiver |
title | New Evidence on Carbetocin: Another Arrow in Our Quiver |
title_full | New Evidence on Carbetocin: Another Arrow in Our Quiver |
title_fullStr | New Evidence on Carbetocin: Another Arrow in Our Quiver |
title_full_unstemmed | New Evidence on Carbetocin: Another Arrow in Our Quiver |
title_short | New Evidence on Carbetocin: Another Arrow in Our Quiver |
title_sort | new evidence on carbetocin: another arrow in our quiver |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172116/ https://www.ncbi.nlm.nih.gov/pubmed/30287526 http://dx.doi.org/10.9745/GHSP-D-18-00336 |
work_keys_str_mv | AT hodginssteve newevidenceoncarbetocinanotherarrowinourquiver |